Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,921 | -10,345 | -8,433 | -6,901 | -1,656 |
| Depreciation Amortization | 74 | 456 | 361 | 250 | 128 |
| Accounts receivable | 397 | N/A | N/A | 71 | 187 |
| Accounts payable and accrued liabilities | N/A | 220 | -15 | N/A | N/A |
| Other Working Capital | 133 | -1,510 | -1,287 | -981 | -500 |
| Other Operating Activity | -284 | 4,168 | 3,872 | 3,533 | -166 |
| Operating Cash Flow | $-1,601 | $-7,011 | $-5,502 | $-4,028 | $-2,007 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 335 | 320 | N/A | N/A |
| Investing Cash Flow | $N/A | $335 | $320 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -9 | -2 | -2 | -1 |
| Common Stock Issued | N/A | 129 | 64 | N/A | N/A |
| Other Financing Activity | 0 | 3,271 | 3,271 | 3,271 | 1,648 |
| Financing Cash Flow | $N/A | $3,391 | $3,333 | $3,269 | $1,647 |
| Beginning Cash Position | 4,249 | 7,534 | 7,534 | 7,534 | 7,534 |
| End Cash Position | 2,648 | 4,249 | 5,685 | 6,775 | 7,174 |
| Net Cash Flow | $-1,601 | $-3,285 | $-1,849 | $-759 | $-360 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,601 | -7,011 | -5,502 | -4,028 | -2,007 |
| Free Cash Flow | -1,601 | -7,011 | -5,502 | -4,028 | -2,007 |